title: Genetic inducible fate mapping in adult mice using tamoxifen-dependent Cre recombinases.
abstract: The Cre/lox site-specific recombination system allows the control of gene activity in space and time in almost any tissue of the mouse. A major technical advance was the development of tamoxifen-dependent Cre recombinases, such as CreER(T2), that can be activated by administration of tamoxifen to the animal. This powerful tool greatly facilitates the study of gene functions and the generation of more realistic animal models of sporadic human diseases. Another important application of tamoxifen-dependent Cre recombinases is genetic inducible fate mapping (GIFM). In GIFM studies, the inducible Cre/lox system is used to genetically label a defined cell population at a selected time by irreversible activation of the expression of a Cre-responsive reporter transgene. Then, marked cells are detected at later time points to determine how the originally labeled progenitors contribute to specific structures and cell types during pre- and postnatal development. GIFM was initially applied during mouse embryogenesis, but is now increasingly used for cell lineage tracing in adult mice under physiological and pathophysiological conditions. Here we describe the design of GIFM experiments in adult mice as exemplified by CreER(T2)-assisted tracing of vascular smooth muscle cells during the development of atherosclerotic lesions. First, we give an overview of reporter transgenes available for genetic cell marking that are expressed from the Rosa26 locus, such as β-galactosidase and fluorescent proteins. Then we present detailed protocols for the generation of experimental mice for GIFM studies, the induction of cell labeling by tamoxifen treatment, and the detection of marked cells in fixed and live tissues. Each section also provides a discussion of limitations and common pitfalls of GIFM experiments. Most of the protocols can be easily adapted to other developmental stages, cell types, Cre recombinases, and reporter transgenes and, thus, can be used as general guidelines for GIFM studies in mice.
authors: Interfakultäres Institut für Biochemie, Universität Tübingen, Hoppe-Seyler-Str. 4, Tübingen, 72076, Germany.
authors: Susanne
authors: S
authors: Feil
authors: Jana
authors: J
authors: Krauss
authors: Martin
authors: M
authors: Thunemann
authors: Robert
authors: R
authors: Feil
mesh_terms: D000818:Animals; D001947:Breeding; D002454:Cell Differentiation / Q000187:drug effects / Q000235:genetics; D019070:Cell Lineage / Q000235:genetics; D058948:Cell Tracking / Q000379:methods*; D005260:Female; D017930:Genes, Reporter / Q000235:genetics; D005821:Genetic Techniques; D019426:Integrases / Q000378:metabolism*; D008297:Male; D051379:Mice; D016612:Paraffin Embedding; D058226:Plaque, Atherosclerotic / Q000235:genetics; D016133:Polymerase Chain Reaction; D011995:Recombination, Genetic / Q000187:drug effects; D013194:Staining and Labeling; D013629:Tamoxifen / Q000494:pharmacology*; D019076:Transgenes / Q000235:genetics
chemical_list: D013629:Tamoxifen; C045073:Cre recombinase; D019426:Integrases